Clinical Outcomes, Safety, and Cost-Effectiveness Analysis of Two Catheters (Xianrui Da and Medtronic) in Radiofrequency Ablation for Varicose Veins

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorChengdu University of Traditional Chinese Medicine

About this trial

This study aims to systematically compare the clinical efficacy (venous closure rate and symptom relief rate), safety (perioperative and postoperative complications), and cost-effectiveness (direct medical costs) of domestic Xianruida radiofrequency catheter and imported Medtronic catheter in endovenous radiofrequency ablation for varicose veins through a single-center, prospective, non-inferiority randomized controlled trial.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age between 18 and 80 years old.

Clinically diagnosed with primary lower extremity varicose veins, with CEAP grade C2 - C5, and requiring treatment of the great saphenous vein segment.

Doppler ultrasound confirms that the reflux time of the saphenofemoral vein valve is > 1.0 second.

Doppler ultrasound confirms that the diameter of the great saphenous vein in the supine position is > 3mm and < 12mm.

Disqualifiers

Thrombosis in the great saphenous vein, or combined with deep vein thrombosis, or a history of deep vein thrombosis or pulmonary embolism.

Recurrent varicose veins after previous treatment.

Severe tortuosity of the great saphenous vein, with the expectation that the catheter cannot pass through.

Severe lower extremity ischemia (CLI).

Trial design

Design model

Parallel

Treatments tested in this trial

  • Compare the two brands of radiofrequency ablation catheters for the treatment of lower limb varicose veins.

    Procedure/Surgery

    1. Surgical Procedures: Standardized radiofrequency ablation (GSV/SSV closure) was carried out in both groups by the same team. Catheter parameters were set as 120°C and 1 cm/min withdrawal speed. The treatment segment of the great saphenous vein was required to be \>1 cm from the skin before anesthesia. For calf varicose veins, treatment was done after great saphenous vein ablation. * Experimental Group: Utilized Xianruida's catheter with advanced features. Surgical and device - related information was recorded. * Control Group: Used Medtronic's catheter. Similar data were recorded as in the experimental group. 2. Postoperative Management: Consistent for both groups. * Compression: Applied elastic bandage + Class II compression stockings. * Medication: Patients took oral anticoagulants and painkillers as needed, with usage details recorded during follow - up.

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: Experimental Group: Treatment of great saphenous vein varicosity using the Xianruida AcoArt Venous™Experimental treatment 1 intervention
Group B: Control Group: Treatment of great saphenous vein varicosity using the Medtronic ClosureFast™ endovenActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Venous Closure Rate at 12 Months Post-operation

The venous closure rate confirmed by ultrasound 12 months after surgery, categorized as complete closure (no blood flow signal) or partial closure (blood flow signal \< 10 cm).This classification is used to determine the difference in the effect of achieving venous occlusion between the two catheters. Unit of Measure: Percentage of closed veins (%)

Time frame
12 months

Secondary outcomes

1

Change in Aberdeen Varicose Vein Questionnaire (AVVQ) Score from

Change in AVVQ score (range 0-100) at 3, 6, and 12 months to assess patient-reported symptoms.Unit of Measure: Points on scale

Time frame
3, 6, and 12 months
2

Change in Venous Clinical Severity Score (VCSS) from Baseline

Change in VCSS score (range 0-30) at 3, 6, and 12 months after surgery to assess symptom improvement.Unit of Measure: Points on scale

Time frame
3, 6, and 12 months
3

Change in CIVIQ-20 Score from Baseline

Change in CIVIQ-20 score (range 0-100) at 3, 6, and 12 months to assess quality of life.Unit of Measure: Points on scale

Time frame
3, 6, and 12 months
4

Number of Intraoperative Complications

Number of events during surgery, such as perforation or catheter failure.Unit of Measure: Number of events

Time frame
During surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: